Adapting mindfulness-based cognitive therapy for treatment-resistant depression

Cognitive and Behavioral Practice

Volumn 18, Issue 3, 2011, Pages 362-370

  Eisendrath, Stuart ^a   Chartier, Maggie ^b   McLane, Maura ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; LITHIUM; SERTRALINE; VENLAFAXINE;

ACHIEVEMENT; ADULT; ARTICLE; AVOIDANCE BEHAVIOR; CASE REPORT; COGNITIVE THERAPY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXPECTATION; FEMALE; GROUP THERAPY; HUMAN; LIFE STRESS; MAJOR DEPRESSION; MEDITATION; MINDFULNESS BASED COGNITIVE THERAPY; PATIENT ATTITUDE; PRIORITY JOURNAL; PSYCHOTHERAPY; RELAPSE; REMISSION; RUMINATION; SELF CONCEPT; SELF ESTEEM; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 79958053935     PISSN: 10777229     EISSN: 1878187X     Source Type: Journal    
DOI: 10.1016/j.cbpra.2010.05.004     Document Type: Article

References (69)

1. Allen N.B., Chambers R., Knight W. Mindfulness-based psychotherapies: A review of conceptual foundations, empirical evidence and practical considerations. Australian and New Zealand Journal of Psychiatry 2006, 40:285-294.
2. Arch J.J., Craske M.G. Mechanisms of mindfulness: Emotion regulation following a focused breathing induction. Behavior Research and Therapy 2006, 44:1849-1858.
3. Baer R.A. Mindfulness training as a clinical intervention: A conceptual and empirical review. Clinical Psychology: Science and Practice 2003, 10:125-143.
4. Barbee J.G., Conrad E.J., Jamhour N.J. The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder. Journal of Clinical Psychiatry 2004, 65:975-981.
5. Barnes P.M., Powell-Griner E., McFann K., Nahin R.L. Complementary and alternative medicine use among adults: United States, 2002. Advanced Data (343) 2004, 1-19.
6. Beck A.T., Rush A.J., Shaw B.F., Emery G. Cognitive therapy of depression 1979, Guilford, New York.
7. Blier P., Szabo S.T. Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety. Journal of Clinical Psychiatry 2005, 66(Suppl 8):30-40.
8. Broderick P. Mindfulness and coping with dysphoric mood: Contrasts with rumination and distraction. Cognitve Therapy and Research 2005, 29:501-510.
9. Brosschot J.F., Gerin W., Thayer J.F. The perseverative cognition hypothesis: A review of worry, prolonged stress-related physiological activation, and health. Journal of Psychosomatic Research 2006, 60:113-124.
10. Brown K.W.R., Richard M. The benefits of being present: Mindfulness and its role in psychological well-being. Journal of Personality and Social Psychology 2003, 84:822-848.
11. Eisenberg D.M., Ettner S.L., Appel S., Wilkey S., Van Rompay M., Kessler R.C. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 1998, 280(18):1569-1575.
12. Eisendrath S.J., Delucchi K., Bitner R., Fenimore P., Smit M., McLane M. Mindfulness-based cognitive therapy for treatment-resistant depression: A pilot study. Psychotherapy and Psychosomatic 2008, 77:319-320.
13. Fava M. Somatic symptoms, depression, and antidepressant treatment. Journal of Clinical Psychiatry 2002, 63:305-307.
14. Finucane A., Mercer S.W. An exploratory mixed methods study of the acceptability and effectiveness of Mindfulness-Based Cognitive Therapy for patients with active depression and anxiety in primary care. BMC Psychiatry 2006, 6:14.
15. Fresco D.M., Segal Z.V., Buis T., Kennedy S. Relationship of posttreatment decentering and cognitive reactivity to relapse in major depression. Journal of Consulting and Clinical Psychology 2007, 75:447-455.
16. Frewen P., Evans E.M., Maraj N., Dozois D.J.A., Partridge K. Letting go: Mindfulness and negative automatic thinking. Cognitive Therapy & Research 2008, 32:758-774.
17. Greden J.F. Treatment of recurrent depression 2001, American Psychiatric Press, Washington, DC. (1st ed.).
18. Hayes S.C., Luoma J.B., Bond F.W., Masuda A., Lillis J. Acceptance and commitment therapy: Model, processes and outcomes. Behavior Research and Therapy 2006, 44:1-25.
19. Hayes S.C., Strosahl K.D., Wilson K.G. Acceptance and commitment therapy: An experiential approach to behavior change 1999, Guilford Press, New York.
20. Hayes S.C., Wilson K.G., Gifford E.V., Follette V.M., Strosahl K. Experimental avoidance and behavioral disorders: A functional dimensional approach to diagnosis and treatment. Journal of Consulting and Clinical Psychology 1996, 64:1152-1168.
21. Johnstone M. Living with a black dog: His name is depression 2006, Andrews McMeel, Kansas City, MO.
22. Kenny M.A., Williams J.M. Treatment-resistant depressed patients show a good response to Mindfulness-based Cognitive Therapy. Behavior Research and Therapy 2007, 45:617-625.
23. Kessler R.C., Davis R.B., Foster D.F., Wilkey S.A., Van Rompay M.I., Eisenberg D.M. The use of complementary and alternative therapies to treat anxiety and depression in the United States. American Journal of Psychiatry 2001, 158:289-294.
24. Khan A., Dager S.R., Cohen S., Avery D.H., Scherzo B., Dunner D.L. Chronicity of depressive episode in relation to antidepressant-placebo response. Neuropsychopharmacology 1991, 4:125-130.
25. Kingston T., Dooley B., Bates A., Lawlor E., Malone K. Mindfulness-based cognitive therapy for residual depressive symptoms. Psychology and Psychotherapy 2007, 80(Pt 2):193-203.
26. Konarski J.Z., Kennedy S.H., Segal Z.V., Lau M.A., Bieling P.J., McIntyre R.S., et al. Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. Journal of Psychiatry and Neuroscience 2009, 34:175-180.
27. Kuyken W., Byford S., Taylor R.S., Watkins E., Holden E., White K., et al. Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. Journal of Consulting and Clinical Psychology 2008, 76:966-978.
28. Leary M.R., Tate E.B., Adams C.E., Allen A.B., Hancock J. Self-compassion and reactions to unpleasant self-relevant events: The implications of treating oneself kindly. Journal of Personality and Social Psychology 2007, 92:887-904.
29. Lin E.H., Von Korff M., Katon W., Bush T., Simon G.E., Walker E., et al. The role of the primary care physician in patients' adherence to antidepressant therapy. Medical Care 1995, 33:67-74.
30. Linehan M.M. Dialectical behavior therapy for treatment of borderline personality disorder: Implications for the treatment of substance abuse. NIDA Research Monographs 1993, 137:201-216.
31. Luoma J.B.H., Hayes S.C., Walser R.D. Learning ACT-An acceptance and committment therapy skills-training manual for therapists 2007, New Harbinger, Oakland.
32. Ma S.H., Teasdale J.D. Mindfulness-based cognitive therapy for depression: Replication and exploration of differential relapse prevention effects. Journal of Consulting and Clinical Psychology 2004, 72:31-40.
33. MacCoon D., Lutz L.A., Rosenkranz M., Davidson R. Lessons from an active control condition: ″ McMindfulness, shams, and the one-fold path 2007.
34. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45:651-660.
35. McPherson S., Cairns P., Carlyle J., Shapiro D.A., Richardson P., Taylor D. The effectiveness of psychological treatments for treatment-resistant depression: A systematic review. Acta Psychiatrica Scandinavica 2005, 111:331-340.
36. Moore R.G., Garland A. Cognitive therapy for chronic and persistent depression 2003, John Wiley and Sons, Chichester.
37. Nemeroff C.B., Bremner J.D., Foa E.B., Mayberg H.S., North C.S., Stein M.B. Posttraumatic stress disorder: A state-of-the-science review. Journal of Psychiatric Research 2006, 40:1-21.
38. Nemeroff C.B., Heim C.M., Thase M.E., Klein D.N., Rush A.J., Schatzberg A.F., et al. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proceedings of the National Academy of Sciences 2003, 100(24):14293-14296.
39. Nolen-Hoeksema S. The role of rumination in depressive disorders and mixed anxiety/depressive symptoms. Journal of Abnormal Psychology 2000, 109:504-511.
40. Nugent A.C., Neumeister A., Goldman D., Herscovitch P., Charney D.S., Drevets W.C. Serotonin transporter genotype and depressive phenotype determination by discriminant analysis of glucose metabolism under acute tryptophan depletion. Neuroimage 2008, 43:764-774.
41. Papakostas G.I. Augmentation of standard antidepressants with atypical antipsychotic agents for treatment-resistant major depressive disorder. Essential Psychopharmacology 2005, 6(4):209-220.
42. Post R.M. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neuroscience & Biobehavioral Reviews 2007, 31:858-873.
43. Post R.M., Weiss S.R. Convergences in course of illness and treatments of the epilepsies and recurrent affective disorders. Clinical EEG and Neuroscience 2004, 35:14-24.
44. Quitkin F.M. Placebos, drug effects, and study design: A clinician's guide. American Journal of Psychiatry 1999, 156:829-836.
45. Ramel W., Goldin P.R., Carmona P., McQuaid J.R. The effects of mindfulness meditation on cognitive processes and affect in patients with past depression. Cognitive Therapy and Research 2004, 28:433-455.
46. Reiss D. Transmission and treatment of depression. American Journal of Psychiatry 2008, 165:1083-1085.
47. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR?D report. American Journal of Psychiatry 2006, 163:1905-1917.
48. Segal Z., Williams J.M., Teasdale J. Mindfulness-based cognitive therapy for depression 2002, The Guilford Press, New York.
49. Segal Z.V., Kennedy S., Gemar M., Hood K., Pedersen R., Buis T. Cognitive reactivity to sad mood provocation and the prediction of depressive relapse. Archives of General Psychiatry 2006, 63:749-755.
50. Segal Z.V., Williams J.M., Teasdale J.D., Gemar M. A cognitive science perspective on kindling and episode sensitization in recurrent affective disorder. Psychological Medicine 1996, 26:371-380.
51. Souery D., Oswald P., Massat I., Bailer U., Bollen J., Demyttenaere K., et al. Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study. Journal of Clinical Psychiatry 2007, 68:1062-1070.
52. Teasdale J., Barnard P. Affect, cognition and change: Re-modelling depressive thought. Essays in cognitive psychology 1993, 285. Lawrence Erlbaum, Hillsdale, NJ.
53. Teasdale J.D., Moore R.G., Hayhurst H., Pope M., Williams S., Segal Z.V. Metacognitive awareness and prevention of relapse in depression: Empirical evidence. Journal of Consulting and Clinical Psychology 2002, 70:275-287.
54. Teasdale J.D., Segal Z., Williams J.M. How does cognitive therapy prevent depressive relapse and why should attentional control (mindfulness) training help?. Behavior Research and Therapy 1995, 33:25-39.
55. Teasdale J.D., Segal Z.V., Williams J.M., Ridgeway V.A., Soulsby J.M., Lau M.A. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting and Clinical Psychology 2000, 68:615-623.
56. Thase M.E., Friedman E.S., Howland R.H. Management of treatment-resistant depression: Psychotherapeutic perspectives. Journal of Clinical Psychiatry 2001, 62(Suppl 18):18-24.
57. Treynor W., Gonzalez R., Nolen-Hoeksema S. Rumination reconsidered: A psychometric analysis. Cognitve Therapy and Research 2003, 27:247-259.
58. Trivedi M.H., Fava M., Wisniewski S.R., Thase M.E., Quitkin F., Warden D., et al. Medication augmentation after the failure of SSRIs for depression. New England Journal of Medicine 2006, 354(12):1243-1252.
59. Trivedi M.H., Rush A.J., Crismon M.L., Kashner T.M., Toprac M.G., Carmody T.J., et al. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Archives of General Psychiatry 2004, 61(7):669-680.
60. Vythilingam M., Heim C., Newport J., Miller A.H., Anderson E., Bronen R., et al. Childhood trauma associated with smaller hippocampal volume in women with major depression. American Journal of Psychiatry 2002, 159(12):2072-2080.
61. Watkins E., Scott J., Wingrove J., Rimes K., Bathurst N., Steiner H., et al. Rumination-focused cognitive behaviour therapy for residual depression: A case series. Behavior Research and Therapy 2007, 45:2144-2154.
62. WHO. (2001). Chapter 2: Burden of mental and behavioral disorders. WHO Report 2001. Retrieved December 16, 2010, at http://www.who.int/whr/2001/chapter2/en/index3.html.
63. Wijeratne C., Sachdev P. Treatment-resistant depression: Critique of current approaches. Australian and New Zealand Journal of Psychiatry 2008, 42:751-762.
64. Williams J.M., Alatiq Y., Crane C., Barnhofer T., Fennell M.J., Duggan D.S., et al. Mindfulness-based Cognitive Therapy (MBCT) in bipolar disorder: Preliminary evaluation of immediate effects on between-episode functioning. Journal of Affective Disorders 2007.
65. Wright J. Cognitive-behavior therapy for chronic depression. Psychiatric Annals 2003, 33:777-784.
66. Wright J., Basco M.R., Thase M.E. Learning cognitive-behavior therapy: An illustrated guide 2006, Amercan Psychiatric Publishing, Washington, DC.
67. Young S. Break through pain: A step-by-step mindfulness meditation program for transforning chronic and acute pain 2004, Sounds True, Inc, Boulder.
68. Zettle R.D. ACT for depression 2007, New Harbinger, Oakland.
69. Zettle R.D., Hayes S.C. Brief ACT treatment of depression. Handbook of brief cognitive behaviour therapy 2002, 35-54. Wiley, Chichester, England. F. Bond, W. Dryden (Eds.).